COVID-eVax, an electroporated DNA vaccine candidate encoding the SARS-CoV-2 RBD, elicits protective responses in animal modelsAntonella Conforti, Maria Rosaria Capobianchi, Emanuele Marra et al.|Molecular Therapy|2021Cited by 70
Profiling Antibody Response Patterns in COVID-19: Spike S1-Reactive IgA Signature in the Evolution of SARS-CoV-2 InfectionGabriel Siracusano, Lucia Lopalco, Chiara Brombin et al.|Frontiers in Immunology|2021Cited by 33
Cost-effectiveness of blood culture and a multiplex real-time PCR in hematological patients with suspected sepsis: an observational propensity score-matched studyNicasio Mancini, Massimo Clementi, Massimiliano Povero et al.|Expert Review of Molecular Diagnostics|2014Cited by 11
Detection of low-level HCV variants in DAA treated patients: comparison amongst three different NGS data analysis protocolsValeria Caputo, Nicola Clementi, Roberta A. Diotti et al.|Virology Journal|2020Cited by 6
COVID- <i>e</i> Vax, an electroporated plasmid DNA vaccine candidate encoding the SARS-CoV-2 Receptor Binding Domain, elicits protective immune responses in animal models of COVID-19Antonella Conforti, Maria Rosaria Capobianchi, Emanuele Marra et al.|bioRxiv (Cold Spring Harbor Laboratory)|2021Cited by 2